The India business, accounting for a third of the company’s total revenues, grew at 11%. This is a volume-led growth aided by new product launches. Sun’s India business grew higher than the Indian Pharma market growth. The company launched 14 new products during the quarter. The India business, accounting for a third of the company’s total revenues, grew at 11%. This is a volume-led growth aided by new product launches. Sun’s India business grew higher than the Indian Pharma market growth. The company launched 14 new products during the quarter. Economic Times
November 27, 2024
Headlines
